news & press

Here is what's up at Genesis Biosciences.

Genesis Biosciences announced today that its US business has been awarded ISO 9001:2008 accreditation. ISO 9001:2008 is a globally recognized official quality management system standard issued by the International Organization for Standardization (ISO). This accreditation confirms that Genesis Biosciences’ quality management system was found to be in complete compliance with ISO standards following a rigorous audit.

“Following significant investment and the many improvements made at the Lawrenceville facility, Genesis Biosciences were successfully audited against the internationally recognised Quality Standard; ISO 9001:2008”...

As part of our constant endeavour to spearhead new developments in the biological field, Genesis Biosciences has implemented an internship program in both its European and US facilities. 

Our technical teams on both sides of the Atlantic have always prided themselves on their up to date knowledge of advances in scientific and research and development techniques which allow us to create the most effective, high performance, scientifically verified and validated biological products for our customers. The internship program will play a significant part in continuing to bring the latest scientific developments to Genesis...

The Genesis Biosciences European facility was first approved for certification against ISO 14001:2004 in February 2013.  Surveillance assessments are the heart of the post-certification process for ISO 14001 certification and Genesis Bioscience are subject to these audits on an annual basis. 

In February 2014 the company was audited against the standard by SGS (a leading provider of certification services) and the audit was completed with no corrective actions raised. 

“The successful surveillance audit shows that Genesis Biosciences continues to be committed to its environmental objectives” stated Debbie...

The Genesis Biosciences European facility completed its first re-certification, having come to the end of the three year certification cycle, in May 2013. The re-certification was successful with no corrective actions. In July 2014 the first annual surveillance of the current three year certification cycle was carried out and, once again, no corrective actions were raised.

“Our recertification in 2013 with no corrective actions and the recent audit with no corrective actions shows that Genesis Biosciences continues to be committed to quality objectives” stated Debbie Williams, the European Operations Manager who is also responsible...

Genesis Biosciences, with headquarters in both the U.S. (Lawrenceville, GA) and Europe (Cardiff, Wales), is a global leader in custom fermentation, microbial product formulation and antimicrobial product development. The company has announced today that its European business has been awarded ISO 14001 certification accreditation.  ISO 14000 is a family of standards related to environmental management that exists to help organizations minimize how their operations negatively affect the environment, comply with applicable laws, regulations, and other environmentally oriented requirements, and...

Genesis Biosciences, with headquarters in both the U.S. (Lawrenceville, GA) and Europe (Cardiff, Wales), is a global leader in custom fermentation, microbial product formulation and antimicrobial product development.

The company has announced today that its European business has passed its ISO 9001 recertification audit. Maintenance of ISO 9001 accreditation is confirmed through a program of annual surveillance visits and a three yearly re-certification audit. ISO 9001:2008 is a globally recognized official quality management system standard issued by the International Organization for...

Introducing EVOGEN the unique, eco-benign, application-specific and performance-driven range of microbial products from Genesis Biosciences. Evogen is the only range of microbial products with such comprehensive, scientifically validated and verified performance data. 

...

LAWRENCEVILLE, Georgia and CARDIFF, Wales – September 21, 2011– Genesis Biosciences, a global leader in custom fermentation, microbial product formulation and antimicrobial product development, announced today that Casey Smallwood has been promoted to vice president of operations. Additionally, Mauricio Amaya and Amit Choksi have been promoted to laboratory manager and fermentation manager, respectively, and Prasanth Maddipati joins Genesis as a new fermentation scientist. These team members will be located in Genesis’ newly renovated U.S. fermentation and manufacturing facility in Lawrenceville, GA.

“Casey,...

LAWRENCEVILLE, Georgia and CARDIFF, Wales – June 16, 2011– Genesis Biosciences, a global leader in custom fermentation, microbial product formulation and antimicrobial product development, announced today that it received the Pulire Innovation Award in the chemical products category for its e card sanitary bin treatment. This prestigious award, which honors creative products, solutions and entrepreneurial ideas in the professional cleaning and environmental hygiene field, was presented to Genesis during the Pulire Exhibition in Verona last month. Genesis’ e card is the latest addition to its Biosan series of products for...

LAWRENCEVILLE, Georgia and CARDIFF, Wales – January 6, 2011 – Genesis Biosciences, a global leader in custom fermentation, microbial product formulation and antimicrobial product development, announced today that its European business, based in Cardiff, Wales, received ISO 9001:2008 accreditation. ISO 9001:2008 is a globally recognized official quality management system standard issued by the International Organization for Standardization (ISO). This accreditation confirms that Genesis Biosciences’ quality management system was found to be in complete compliance with ISO standards following a rigorous audit.

“From...